Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Trends in Pharmacological Sciences
|
December 7, 2007
Connecting chemosensitivity, gene expression and disease
David G Covell
Plos One
|
August 10, 2017
A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib
David G Covell
Plos One
|
April 28, 2021
Bioinformatic analysis linking genomic defects to chemosensitivity and mechanism of action
David G Covell
Plos One
|
July 2, 2015
Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia
David G Covell
Plos One
|
October 12, 2012
Integrating constitutive gene expression and chemoactivity: mining the NCI60 anticancer screen
David G Covell
Current Medicinal Chemistry. Anti-Cancer Agents
|
April 8, 2003
Antimitotic peptides and depsipeptides
Ernest Hamel, David G Covell
Genomics
|
January 3, 2006
Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen
Ruili Huang, Anders Wallqvist, David G Covell
Molecular Cancer Therapeutics
|
August 19, 2007
Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening data
David G Covell, Ruili Huang, Anders Wallqvist
Molecular Cancer Therapeutics
|
September 21, 2006
Targeting changes in cancer: assessing pathway stability by comparing pathway gene expression coherence levels in tumor and normal tissues
Ruili Huang, Anders Wallqvist, David G Covell
Journal of Chemical Information and Modeling
|
June 9, 2007
Chemoinformatic analysis of NCI preclinical tumor data: evaluating compound efficacy from mouse xenograft data, NCI-60 screening data, and compound descriptors
Anders Wallqvist, Ruili Huang, David G Covell
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Trends in Pharmacological Sciences
|
December 7, 2007
Connecting chemosensitivity, gene expression and disease
David G Covell
Plos One
|
August 10, 2017
A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib
David G Covell
Plos One
|
April 28, 2021
Bioinformatic analysis linking genomic defects to chemosensitivity and mechanism of action
David G Covell
Plos One
|
July 2, 2015
Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia
David G Covell
Plos One
|
October 12, 2012
Integrating constitutive gene expression and chemoactivity: mining the NCI60 anticancer screen
David G Covell
Current Medicinal Chemistry. Anti-Cancer Agents
|
April 8, 2003
Antimitotic peptides and depsipeptides
Ernest Hamel, David G Covell
Genomics
|
January 3, 2006
Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen
Ruili Huang, Anders Wallqvist, David G Covell
Molecular Cancer Therapeutics
|
August 19, 2007
Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening data
David G Covell, Ruili Huang, Anders Wallqvist
Molecular Cancer Therapeutics
|
September 21, 2006
Targeting changes in cancer: assessing pathway stability by comparing pathway gene expression coherence levels in tumor and normal tissues
Ruili Huang, Anders Wallqvist, David G Covell
Journal of Chemical Information and Modeling
|
June 9, 2007
Chemoinformatic analysis of NCI preclinical tumor data: evaluating compound efficacy from mouse xenograft data, NCI-60 screening data, and compound descriptors
Anders Wallqvist, Ruili Huang, David G Covell
Page
of 4